This report provides a detailed analysis of the sustainability performance of 86 European companies in the Biotechnologies & Pharmaceuticals sector, based on EthiFinance’s ESG Ratings assessment conducted in 2024 with data reported for fiscal year 2023. The study highlights key trends and findings on the sector’s most material aspects across [...]

Environmental change related to human activities has become a major systemic risk that financial institutions must take into account. While climate-related regulations have emerged, and with them the need to estimate the effects of climate change and transition efforts on economies and financial stability, the more global issue of nature [...]

Opinion by Thomas Dilasser, Chief Rating Officer – Corporates & Project Finance at EthiFinance In today’s financial markets, young companies often prioritize storytelling to attract investors, focusing on bold narratives instead of sustainable cashflow generation. With interest rates decreasing and financing opportunities growing, the temptation to overpromise is high—but this approach carries [...]

European Survey 2023 by EthiFinance Our report provides an overview of how European companies manage the increasing threat of cyber risks. Main take-aways from our report: 1. On average, cybersecurity management across European companies has steadily and strongly increased over the past three years. 2. Austrian companies receive the highest [...]